Enzymes Market to Reach USD 10.59 Billion with 5.7% CAGR: AMR
15 janv. 2021 09h30 HE
|
Allied Market Research
Portland, OR, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Enzymes Market by Type (Protease, Carbohydrase, Lipase, Polymerase and Nuclease, and Other Types),...
Global Enzymes Market to Surpass USD 17,875.7 Million and Rise at a CAGR of 9.4% Owing to COVID-19 Chaos by 2026 – Exclusive Report [150 Pages] by Research Dive
15 déc. 2020 09h05 HE
|
Research Dive
New York, USA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- As per a Research Dive published report, the global enzymes market valued for $8,900.0 million in 2018 and is estimated to surpass $17,875.7 million...
Antiseptics and Disinfectants Market to Reach USD 30.17 Billion By 2027 | CAGR of 6.6%: Reports and Data
11 déc. 2020 11h09 HE
|
Reports and Data
New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- The rising occurrences of infectious diseases and growing awareness of sanitation among consumers is boosting the demand of the market. The Global...
Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
23 juin 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif. and SAN DIEGO, June 23, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular...
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
16 juin 2020 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new...
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
01 juin 2020 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif. and JUPITER, Fla., June 01, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Alphazyme...
Codexis to Participate in Two Virtual Investment Conferences
27 mai 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment...
Codexis to Present at the UBS Virtual Healthcare Conference
11 mai 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at the UBS Virtual Healthcare...
Codexis Reports First Quarter 2020 Financial Results
07 mai 2020 16h05 HE
|
Codexis, Inc.
R&D revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19 potential impact Conference...
Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
06 mai 2020 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone...